Enzon Pharmaceuticals, Inc.’s (ENZN) MACD indicator has moved into bearish territory with a reading of -0.1812. The Zacks #5 Rank (“Strong Sell”) stock decreased slightly to $10.50 in morning trade. The Zacks Consensus Estimate on the company’s earnings for the year ending December 2011 has decreased by 5 cents over the past week to 11 cents per share.
Be the first to comment